VRAY Stock Recent News
VRAY LATEST HEADLINES
ViewRay (NASDAQ: VRAY ) stock is falling hard on Monday after the MRI company announced its voluntary Chapter 11 bankruptcy filing! According to the company's bankruptcy filing, ViewRay intends to pursue the sale of its business as part of the Chapter 11 process.
ViewRay (VRAY) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.14 per share a year ago.
Magnetic resonance imaging-guided radiation therapy system provider ViewRay, Inc. has shocked investors with a severe revenue and cash flow warning. Expected 2023 revenue growth range slashed from a range of 25% to 40% to a new range of 0% to 15%.
DENVER , April 12, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) will hold a conference call to discuss results on Thursday, April 13, 2023, at 8:00 AM ET. The dial-in number for domestic callers is (888) 886-7786.
ViewRay, Inc. (NASDAQ:VRAY ) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Participants Matt Harrison - Director of IR Scott Drake - President and CEO Bill Burke - CFO Conference Call Participants Rick Wise - Stifel Jason Bednar - Piper Sandler Chris Pasquale - Nephron Research Suraj Kalia - Oppenheimer Operator Good afternoon, ladies and gentlemen. And welcome to the ViewRay Q4 2022 Earnings Call.
ViewRay (VRAY) delivered earnings and revenue surprises of 6.25% and 0.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ViewRay has continued growth in order momentum. Its stock price has moved sideways into the new year, adding another attractive entry point.
DENVER , Jan. 31, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today details relating to the release of fourth quarter 2022 financial results. ViewRay will hold a conference call to discuss results on Monday, February 27, 2023 at 4:30 p.m.
Revised FY22 revenue guidance with management more confident on the lower end of range. Backlog continues to grow, ending 26% higher to $350mm for the third quarter.
DENVER , Nov. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Stifel 2022 Healthcare Conference. Scott Drake, President and Chief Executive Officer, and Zach Stassen, Chief Financial Officer, will participate in a fireside chat at 2:25 p.m.